Assay Detail
Functional
CHEMBL4666227
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Anticancer activity against human MCF7 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
22
Total Activities
22
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | MCF7 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 22 | 4.42 | 5.41 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL2035835 | CLAULANSINE F | — | 1 | 5.41 |
| CHEMBL786 | TAMOXIFEN CITRATE | 4.0 | 1 | 5.21 |
| CHEMBL4780732 | — | — | 1 | 4.53 |
| CHEMBL4777848 | — | — | 1 | 4.48 |
| CHEMBL4756640 | — | — | 1 | 4.35 |
| CHEMBL4760705 | — | — | 1 | 4.32 |
| CHEMBL4781975 | — | — | 1 | 4.29 |
| CHEMBL4758896 | — | — | 1 | 4.23 |
| CHEMBL4785995 | — | — | 1 | 4.19 |
| CHEMBL4756222 | — | — | 1 | 4.19 |
| CHEMBL4764555 | — | — | 1 | 4.18 |
| CHEMBL4788145 | — | — | 1 | 4.15 |
| CHEMBL4749329 | — | — | 1 | 4.14 |
| CHEMBL4795902 | — | — | 1 | 4.14 |
| CHEMBL4762745 | — | — | 1 | - |
| CHEMBL4747972 | — | — | 1 | - |
| CHEMBL53463 | DOXORUBICIN | 4.0 | 1 | - |
| CHEMBL4752610 | — | — | 1 | - |
| CHEMBL4742668 | — | — | 1 | - |
| CHEMBL4785117 | — | — | 1 | - |
| CHEMBL4746389 | — | — | 1 | - |
| CHEMBL4747612 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL2035835 | CLAULANSINE F | IC50 | = | 3900.0 | nM | 5.41 |
| CHEMBL786 | TAMOXIFEN CITRATE | IC50 | = | 6200.0 | nM | 5.21 |
| CHEMBL4780732 | — | IC50 | = | 29400.0 | nM | 4.53 |
| CHEMBL4777848 | — | IC50 | = | 32800.0 | nM | 4.48 |
| CHEMBL4756640 | — | IC50 | = | 44900.0 | nM | 4.35 |
| CHEMBL4760705 | — | IC50 | = | 48200.0 | nM | 4.32 |
| CHEMBL4781975 | — | IC50 | = | 51800.0 | nM | 4.29 |
| CHEMBL4758896 | — | IC50 | = | 59100.0 | nM | 4.23 |
| CHEMBL4785995 | — | IC50 | = | 64300.0 | nM | 4.19 |
| CHEMBL4756222 | — | IC50 | = | 64900.0 | nM | 4.19 |
| CHEMBL4764555 | — | IC50 | = | 65600.0 | nM | 4.18 |
| CHEMBL4788145 | — | IC50 | = | 70700.0 | nM | 4.15 |
| CHEMBL4749329 | — | IC50 | = | 71900.0 | nM | 4.14 |
| CHEMBL4795902 | — | IC50 | = | 72400.0 | nM | 4.14 |
| CHEMBL4762745 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL4747972 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL53463 | DOXORUBICIN | IC50 | - | — | - | |
| CHEMBL4752610 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL4742668 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL4785117 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL4746389 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL4747612 | — | IC50 | > | 100000.0 | nM | - |